Presentation Information

[S04-1]Development of cancer-specific therapeutic agents: Perspectives from BNCT and photoimmunotherapy

○Naoya Kondo1,2 (1. NIR-PIT Res. Inst., Kansai Med. Univ., 2. Grad. Sch. Pharm. Sci., Osaka Med. Pharm. Univ.)